Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of Xiaoer Reping Granules in children with acute upper respiratory tract infection
CTR20251348Phase 2Completed
- Sponsor
- Jiuhua Huayuan Pharmaceutical
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xiao'er reping granules in upper respiratory infection (URI), sponsored by Jiuhua Huayuan Pharmaceutical. Started May 2025; status: completed.
02
Drugs
xiao'er reping granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20251348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251348.